Surgery for constipation : systematic review and clinical guidance : Paper 1 : Introduction & Methods by Knowles, C. H. et al.
  
 
 
 
  warwick.ac.uk/lib-publications 
 
 
 
 
 
Original citation: 
The Pelvic floor Society, National Institute for Health Research: Chronic Constipation 
Treatment Pathway (Including: Knowles, C. H., Grossi, U., Horrocks, E. J., Pares, D., 
Vollebregt, P. F., Chapman, M., Brown, S. R., Mercer-Jones, M., Williams, A. B., Hooper, R. J., 
Stevens, N. and Mason, James). (2017) Surgery for constipation : systematic review and 
clinical guidance : Paper 1 : Introduction & Methods. Colorectal Disease, 19 (S3). pp. 5-16. 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/92938   
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work of researchers of the 
University of Warwick available open access under the following conditions. 
 
This article is made available under the Creative Commons Attribution 4.0 International 
license (CC BY 4.0) and may be reused according to the conditions of the license.  For more 
details see: http://creativecommons.org/licenses/by/4.0/   
 
A note on versions: 
The version presented in WRAP is the published version, or, version of record, and may be 
cited as it appears here. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
Surgery for constipation: systematic review and clinical
guidance
Paper 1: Introduction & Methods
C. H. Knowles*, U. Grossi*, E. J. Horrocks*, D. Pares†, P. F. Vollebregt*, M. Chapman‡,
S. R. Brown§, M. Mercer-Jones¶, A. B. Williams**, R. J. Hooper††, N. Stevens††, J. Mason‡‡,
on behalf of the NIHR CapaCiTY working group§§ and The Pelvic floor Society¶¶
*National Bowel Research Centre, Blizard Institute, Queen Mary University London, London, UK, †Hospital Germans Trıas i Pujol, Barcelona, Spain,
‡Good Hope Hospital, Heart of England NHS Trust, Birmingham, UK, §Sheffield Teaching Hospitals, Sheffield, UK, ¶Queen Elizabeth Hospital,
Gateshead NHS Trust, Gateshead, UK, **Guy’s and St Thomas’ NHS Foundation Trust, London, UK, ††Pragmatic Clinical Trials Unit, Blizard Institute,
Queen Mary University of London, London, UK, ‡‡University of Warwick, Coventry, UK, §§National Institute for Health Research: Chronic
Constipation Treatment Pathway, UK, and ¶¶Affiliate section of the Association of Coloproctology of Great Britain and Ireland, London, UK
Abstract
Aim This manuscript provides the introduction and
detailed methodology used in subsequent reviews to
assess the outcomes of surgical interventions with the
primary intent of treating chronic constipation in adults
and to develop recommendations for practice.
Method PRISMA guidance was adhered to throughout.
A literature search was performed in public databases
between January 1960 and February 2016. Studies that
fulfilled strictly-defined PICOS (patients, interventions,
controls, outcome, and study design) criteria were
included. The process involved two groups of partici-
pants: (i): ‘a clinical guidance group’ of 18 UK experts
(including junior support) who performed the system-
atic reviews and produced summary evidence statements
(SES) based strictly on data synthesis in each review.
The same group then produced prototype graded prac-
tice recommendations (GPRs) based on coalescence of
SES and expert opinion; (ii): a European Consensus
group of 18 ESCP (European Society of Coloproctol-
ogy) nominated experts from nine European countries
evaluated the appropriateness of each prototype GPR
based on published RAND/UCLA methodology.
Results An overview of the search results is provided in
this manuscript. A total of 156 studies from 307 full
text articles (from 2551 initially screened records) were
included, providing data on procedures characterized
by: (i) colonic resection (n = 40); (ii) rectal suspension
(n = 18); (iii) rectal wall excision (n = 44); (iv) recto-
vaginal septum reinforcement (n = 47); (v) sacral nerve
stimulation (n = 7). The overall quality of evidence was
poor with 113/156 (72.4%) studies providing only
Oxford level IV evidence. The best evidence was
extracted for rectal excisional procedures, where the
majority of studies were Oxford level I or II. The five
subsequent reviews provide a total of 99 SES (reflecting
perioperative variables, efficacy, harms and prognostic
variables) that contributed to 100 prototype GPRs cov-
ering patient selection, procedural considerations and
patient counselling. The final manuscript details the
85/100 GPRs that were deemed appropriate by Euro-
pean Consensus (remaining 15 were all uncertain) and
future research recommendations.
Conclusion This manuscript and the following 6 papers
suggest that the evidence base for surgical management
of chronic constipation is currently poor although some
expert consensus exists on best practice. Further studies
are required to inform future commissioning of treat-
ments and of research funding.
Keywords Constipation, surgery, obstructed defaecation
Introduction
Constipation is common in adults and children with up
to 20% of the population reporting symptoms
depending on the definition used (2–28% adults; 0.7–
30% children) [1–3]. Chronic constipation (CC), usu-
ally defined as more than 6 months of symptoms, is less
common but results in 0.5 million UK GP consulta-
tions per annum. A proportion of the population suffer
symptoms that are both chronic and more disabling
(probably about 0.4% population) [4]. Such patients,
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who are predominantly female [5], are usually referred
to secondary care with many progressing to tertiary spe-
cialist investigation. Patient dissatisfaction is high in this
group; nearly 80% feel that laxative therapy is unsatisfac-
tory [6] and the effect of symptoms on measured QOL
is significant [7]. CC consumes significant healthcare
resources. In the US in 2012, a primary complaint of
constipation was responsible for 3.2 million physician
visits resulting in (direct and indirect) costs of $1.7 bil-
lion [8]. In the UK, it is estimated 10% of district nurs-
ing time is spent on bowel control [9] and the annual
spend on laxatives exceeds £117 m, with 18.3 million
prescriptions in 2014 of which 91% were for stimulant
and osmotic laxatives (Health and Social Care Informa-
tion Centre) [10].
The act of defaecation is dependent on the coordi-
nated functions of the colon, rectum and anus. Consid-
ering the complexity of neuromuscular (sensory and
motor) functions required to achieve planned, con-
scious, and effective defaecation [11], it is no surprise
that disturbances to perceived ‘normal’ function occur
commonly at all stages of life. Clinically, such problems
commonly lead to symptoms of obstructed defaecation
e.g. straining; incomplete, unsuccessful or painful evacu-
ation; bowel infrequency; abdominal pain and bloating.
After exclusion of secondary causes (obstructing colonic
lesions, neurological, metabolic and endocrine disor-
ders), the pathophysiology of CC can broadly be
divided into problems of colonic contractile activity
(and thus stool transit) and problems allied to rectal
emptying (evacuation disorder). A combination of clini-
cal expertise and specialist radio-physiological investiga-
tions can determine which patients have slow colonic
transit, evacuation disorder, both (in whom transit is
usually characterized by a left-sided delay) or neither
(no abnormality found with current tests) [12]. Evacua-
tion disorders can be further subdivided into those with
a structurally significant pelvic floor abnormality (usually
as a consequence of pelvic floor weakness or injury) e.g.
rectocoele or internal prolapse (intussusception), and
those characterized by a dynamic failure of evacuation
without structural abnormality: most commonly termed
‘functional defaecation disorder (FDD) [13]’ (Fig. 1).
The management of CC is a major problem due to
its high prevalence and lack of widespread specialist
expertise. In general, a step-wise approach is under-
taken, with first line conservative treatment such as life-
style advice and laxatives (primary care) followed by
nurse-led bowel re-training programs, sometimes
including focused biofeedback and psychosocial support
(secondary/tertiary care). Although these treatments
may improve symptoms in more than half of patients
[14], patients with intractable symptoms and impaired
QOL may subsequently be offered a range of surgical
interventions.
Surgical decision-making is greatly influenced by local
expertise, commissioning or reimbursement, and per-
sonal enthusiasm for particular interventions. While
robust diagnosis of specific pathophysiologies combined
with multidisciplinary team discussion may help direct
surgery, in the absence of an agreed pathway to stratify
patients, there is a current large and difficult-to-justify
variation in surgical practice that continues to risk inade-
quately-informed and potentially harmful interventions
being offered. The need to reduce such variations in prac-
tice, based on available evidence, has been a recurrent
theme of recent national specialty group discussions (e.g.
ACPGBI) with various initiatives proposed. As part of the
Chronic Constipation Treatment PathwaY (CapaCiTY)
programme funded by National Institute of Health
Research (NIHR), a multi-disciplinary working group
was convened in July 2014 to address this need. This
group of medical and nursing experts included members
of The Pelvic Floor Society and urogynaecology expertise
derived from the International Continence Society (ICS).
As a prelude to developing new evidence from trials
within the CapaCiTY programme, it was agreed that the
current surgical evidence base would benefit from coales-
cence in the form of systematic review and graded prac-
tice recommendations. This paper and the accompanying
subsequent six papers address this aim.
Methods
Systematic review
Protocol and registration
The authors developed the protocol for review, detail-
ing pre-specified methods of the analysis and eligibility
for the review in accord with 2009 PRISMA guidance
[15] using also the new reporting elements derived
from the 2016 harms checklist [16]. While the protocol
was not registered, a description of the NIHR Capa-
CITY programme is available in the public domain
(http://www.isrctn.com/ISRCTN11747152) and has
been presented nationally (DDF meeting, London
2015; National Pelvic Floor Meeting, Manchester
2015).
Eligibility criteria
Study characteristics
Study characteristics were defined using the PICOS
framework. Search term definitions were inclusive, pro-
moting a sensitive search of studies reporting surgical
interventions for chronic constipation.
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Population: The review aimed to identify studies of
patients undergoing surgical interventions with the pri-
mary intent of treating chronic constipation. The defini-
tion of chronic constipation is neither straightforward
nor uniformly applied [17]. On this basis, all common
terms encompassing problematic defecation were used
(see search strategy syntax: Appendix I). However, sev-
eral pelvic floor procedures may be performed com-
monly for non-chronic constipation indications.
Examples include pelvic organ prolapse syndromes
where the physical prolapse or other organ dysfunctions
of the vagina or bladder are the main motivation for
surgery. While such patients invariably also have some
degree of defaecatory problems, and their perioperative
data could still be used to inform procedural safety,
these patients may phenotypically differ at baseline and
in response to surgical intervention even if the interven-
tion itself is identical or at least similar. Cochrane
reviews such as ‘surgical repair of pelvic organ prolapse
in women’ [18] and of surgical management of external
rectal prolapse [19] include some RCTs where defaeca-
tory symptoms are recorded as a secondary outcome or
as a complication but not as a primary presenting com-
plaint of the population studied. Thus these were ineli-
gible for inclusion. Similarly, for colonic excisional
procedures, patients with the very rare diagnoses of
adult Hirschsprung disease or idiopathic megacolon-
megarectum [20] were considered distinct from chronic
constipation and thus not included. Some studies
reported outcomes on two populations, only one of
which was eligible e.g. internal and external rectal pro-
lapse. Where such data could not be separated by
population, the study was also deemed ineligible for
inclusion.
A minimum population sample of 20 patients was
imposed for eligibility. This threshold was taken to
exclude case reports and small case series that often
reported a single surgeon’s personal experience or early
experience of experimental procedures.
Intervention: Surgical procedures for chronic consti-
pation are subject to heterogeneous descriptions. On
this basis, an iterative approach was taken by cross refer-
encing e.g. with textbook reference lists to ensure that
all terms in common usage were incorporated in the
eventual search strategy. These included some genuine
procedural variations but also multiple small changes in
syntax for the same procedure e.g. ‘stapled transanal
rectal resection’ vs ‘stapled transanal rectum resection’.
A decision was taken by the review team that results
would be grouped by five main approaches to surgically
treating chronic constipation: (i) colonic resection, (ii)
hitching procedures of the rectum (rectal suspension);
(iii) excisional procedures of the rectal wall (rectal exci-
sion); (iv) reinforcement of the rectovaginal septum
(RV reinforcement); and (v) sacral nerve stimulation
(SNS). This approach was taken because initial review
(Oct 2014) determined that other procedures either
lacked sufficient evidence for review. The first major
exclusion on this basis were stomas leading to intestinal
discontinuity or for the purpose of administering bowel
irrigation (continence enema). It is acknowledged that
in the real world many patients have stomas either
deliberately or as an eventual outcome of other surgery.
Figure 1 Schematic of pathophysiology
of chronic constipation.
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However, eligible studies were sparse after application
of inclusion criteria and markedly heterogeneous
between and within studies (patients and techniques).
Other procedures were excluded if still considered
experimental e.g. colonic exclusion procedures [21].
Comparisons: Studies were eligible regardless of
whether they were retrospective or prospective in
design, controlled or uncontrolled. Only a minority of
studies reported more than one procedure or more than
one population.
Outcomes: Studies were broadly eligible if they pro-
vided extractable data on benefit (treatment efficacy),
risk (harms) or both. For efficacy, inclusion necessitated
the acceptance of the huge disparity in quality of out-
comes reporting that are well acknowledged in the liter-
ature [14], with a heavy reliance on estimates of global
patient satisfaction with the procedure (an indirect
measure of the patients own judgement of their post-
operative state compared to their pre-operative state).
Studies of physiological and anatomical outcomes alone
were excluded since these are generally regarded as a
poor surrogate of efficacy in this patient population
[22]. Because the outcomes of surgical interventions for
chronic constipation are known to exhibit a ‘honey-
moon period’ in the months immediately following sur-
gery, a minimum (mean or median) follow up of
12 months was applied for eligibility. It is acknowl-
edged that enforcement of this criteria excluded some
level I studies. Several studies reported the outcomes of
more than one procedure. Where such data could not
be separated by procedure, these were not included
(often resulting in study ineligibility).
Report characteristics
Year of publication: Any publication date was eligible as
covered by database search from 1960 to the date of
final search (22nd February 2016).
Language: Due to the large number of studies
retrieved, it was decided to include only studies with
full text in the English language. While the numbers of
foreign language studies were small, these have been
detailed for the reader in ‘reasons for exclusion’ at the
full-text stage (rather than at the abstract screening
stage). There is reasonable evidence to suggest that
searching only in English does not have an adverse
effect on the quality of systematic reviews [23].
Type of study: Only peer-reviewed publications
reporting primary data were eligible. Thus reviews, edi-
torials, letters and other forms of secondary expert
opinion were excluded at the screening stage. Only full
manuscripts were eligible thus conference abstracts and
proceedings were also excluded. No constraint was
imposed based on level of evidence. This decision was
taken in the knowledge that the vast majority of data
would be extracted from case series rather than higher
quality study types.
Information sources
The senior author (CK) performed a comprehensive
search of the literature on 22nd February 2016 using
PubMed and Evidence Based Medicine reviews (includ-
ing the Cochrane database of systematic reviews and the
Cochrane central register of controlled trials). A prelim-
inary search in 2014 had determined that Embase and
Web of Science led to almost 2000 duplicate records
with no additional yield. Search terms used a sensitive
combination of population, intervention and report
terms. A keyword and hand search was used within rele-
vant Cochrane systematic reviews. The specific search
terms are listed in Appendix I.
Study selection
Screening was performed at the abstract level by the
senior author (CK), excluding studies not meeting eligi-
bility criteria where this could be readily determined
from the abstract alone. Full-text copies of all remaining
English language studies were obtained and assessed by
reviewers, who were un-blinded to the names of studies,
authors, institutions or publications. Disagreement
regarding inclusion was resolved by the senior author
(CK). Duplicate data sets generated from the same
cohort of patients were excluded with the larger popula-
tion size and longer follow-up cohort included at the
expense of earlier reports from the same cohort. In
instances of doubt, authors from the relevant institu-
tions were contacted to confirm or refute any repetition
of results (performed on three occasions).
Search results were cross-referenced to bibliographies
from other sources (previous reviews and book chap-
ters). Care was taken that any studies missed by the
original search met the strict inclusion criteria and did
not circumnavigate the carefully-defined search strategy
especially in relation to population terms.
Data collection process
Outcome data were extracted by the junior authorship
team (UG, EJH, DP, PFV) paired with one senior
author for each procedure: colonic resections (CK); rec-
tal hitching procedures (SB); rectovaginal septum rein-
forcement (ABW); rectal wall excision (MM-J); sacral
nerve stimulation (SP). Data were extracted to a stan-
dardized template (Microsoft Excel spreadsheet) includ-
ing study characteristics and outcome data (see below).
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For each procedure, one reviewer extracted the data
and one verified content.
Data items
A full list of data fields is included in Table 1 (with
annotation). These followed the PICOS framework with
outcomes broadly divided into those assessing harms
(intra- and perioperative complications and long-term
adverse outcomes), and those assessing efficacy: global
success ratings and functional outcomes (organized into
validated symptom, QOL scoring instruments and indi-
vidual symptoms). For perioperative complications,
some consideration was given to classifying complica-
tions by established systems e.g. Clavien-Dindo however
inconsistencies in reporting made this unfeasible. Data
were not collected in relation to cost effectiveness which
was deemed to fall outside the remit of the process
aims. To simplify data extraction and presentation, for
ordinal data, summary statistics were extracted as mean
or median (with SD when provided).
Individual study quality and risk of bias
The methodological quality of all individual included
studies was assessed by the senior author (CK) and classi-
fied in accord with Oxford CEBM levels of evidence defi-
nitions for ‘therapy or harm’ [16]. The following rules
were applied accepting that distinguishing study designs
can be problematic for observational studies [24]:
1 A study was deemed prospective if this was categori-
cally stated or if patients were ‘enrolled’ or ‘re-
cruited’ to a study that systematically recorded pre-
and post-operative data. All other studies were
assumed to be retrospective.
2 A cohort study was defined as one designed to address a
clear stated aim or hypothesis using specified analytical
methods. In general, these included a comparison
group related either to the relative efficacy of more than
one specified procedure or to patient selection where a
specified baseline ‘risk factor’ was analysed in relation to
relative success or failure of the intervention.
3 A case series was defined as a report of observations
based on clinical practice. Such studies may generate
hypotheses by post-hoc case comparisons.
4 For randomized trials and cohort studies, Cochrane
risk of bias tools were applied [http://ohg.cochrane.
org/sites/ohg.cochrane.org/files/uploads/Risk%20of
%20bias%20assessment%20tool.pdf] and used to dis-
tinguish between high and low quality RCTs
(Oxford level 1b or level 2b) and high and low qual-
ity cohort studies (Oxford level 2b or level 4). Case
control studies were assessed using the National
Institutes of Health (NIH) quality assessment tool
[http://www.nhlbi.nih.gov/health-pro/guidelines/
in-develop/cardiovascular-risk-reduction/tools/case-
control] (Oxford level 3b or 4).
Further sub-analysis of the quality of observational
studies (e.g. compliance with STROBE, Newcastle-Ottawa
or MINORS) was not undertaken as it was felt that this
would add little to the overall assessment of quality.
Summary measures
Results were tabulated by outcome and described with
appropriate summary statistics (percentages, means and
ranges). For very rare events, the aggregate number and
denominator were reported. Quantitative data synthesis
was performed for key outcomes using meta-analysis in
STATA SE v14. Pooled proportions and means were
estimated, permitting exploration of heterogeneity and
bias. Where continuous measures failed to report mea-
sures of variance these were approximated as range/4.
Random effect meta-analytic models were estimated to
characterise rates of events and heterogeneity between
studies, with sub-grouping by procedure. Where studies
did not provide data in a useful summary form, available
data were tabulated but not included in the meta-analy-
sis. Results were presented as aggregate means with
confidence intervals and graphically displayed within
Forest plots. For pooled studies, the I2 value (reflecting
intra-group heterogeneity) was reported and interpreted in
accord with published guidance where 0–40% = hetero-
geneity might not be important, 30–60% = moderate
heterogeneity, 50–70% substantial heterogeneity and
75–100% = considerable heterogeneity [25]. The mag-
nitude and direction of effect, and strength of evidence
P-value from the chi-squared test, were used to inter-
pret the importance of heterogeneity.
Evidence within reviews was predominantly provided
by observational cohort data with relatively few experi-
mental studies (trials) identified. Consequently, the
reviews analyse all studies as individual cohorts, by pro-
cedure, to achieve inclusion and consistency; pooled
findings are compared with the findings of individual
trials. Where several trials were identified within a
review (e.g. rectal excision procedures) meta-analyses
was performed with sub-grouping by procedure and by
evidence grade. Findings by evidence grade were
reported only when they deviated qualitatively from the
overall pooled summary. Given the nature and reporting
of data, study-level meta-regression was not attempted.
Risk of bias across studies
Publication bias was assessed for outcomes where meta-
analysis was performed. Other limited analysis was per-
formed based on study size, design and publication date
where this contributed to interpretation. Subgroup analy-
sis was explored for the main procedural variations.
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Funding statement
This review was funded by the NIHR Programme
Grant for Applied Research Programme (Ref: RP-PG-
0612-20001) who had no role in study design, data
collection, analysis, interpretation, writing of the report
or the decision to submit the paper.
Clinical guidance development
Aims
The process had three main aims:
1 Development of summary evidence statements;
2 Development of graded practice recommendations;
3 Development of summary research recommenda-
tions.
Development of summary evidence statements
Summary evidence statements were produced by the
Clinical Guidance Group (CGG). This group was con-
vened in summer 2014. A final list of participants was
selected primarily from colorectal surgeons, gastroen-
terologists, urogynaecologists and specialist nurses with
a strong interest in functional colorectal and pelvic floor
disorders. This group included all senior authors of the
Table 1 Data field for systematic review.
Data extract Description Notes
Study characteristics
First author Text(num) With citation number
Year publication Text To 2016
Number of pts Number Ordinal integer
Follow up Months Mean or median as documented in study (integer)
Study design Text abbreviation As Oxford CEBM levels of evidence
Evidence grade IA–IV As Oxford CEBM levels of evidence
Population
Disease Text abbreviation As supplied key
Sex ratio Female:male Ratio not simplified
Age Years (integer) Mean or median as supplied (range)
Intervention
Operation (s) Text abbreviation As supplied key
Op duration Minutes Mean (integer)
Length of stay Days Mean to 1 decimal place
Outcomes
Harms
Perioperative
Total cx Percentage % to 1 decimal place
Infective cx Percentage % to 1 decimal place
Bleeding cx Percentage % to 1 decimal place
Proc specific cx Percentage As per specific procedure: % to 1 decimal place
Mortality Percentage % to 1 decimal place
Repeat intervention Percentage Generally procedure specific for complications
or poor functional outcome
Mortality rate Number Absolute number over reported denominator
Adverse long-term symptoms Percentage Some procedural specificity: Includes re-operation
rate where relevant
Efficacy
Global success rating Scale Very commonly employed: % patients with good or
excellent outcomes unless specified
Symptom scores Count Several variably validated summative scoring instruments:
pre and post or post only as available: mean + SD
Individual symptoms Percentage Some procedural specificity: pre and post or post
only as available
QOL measures Count or scale Few instruments used: pre and post or post only as
available: mean + SD
Cx, complications.
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five reviews and associated junior investigators. Method-
ological expertise was provided by Professor James
Mason (University of Warwick), and NHS Specialised
Services stakeholder representation by Mr Mark Chap-
man. A series of meetings followed (Bristol, November
2014; London, June 2015; Manchester, November
2015; and Edinburgh, July 2016) at which the evolving
summary evidence statements (from reviews) were even-
tually ratified and prototype clinical practice recommen-
dations drafted.
The CGG used ‘focus group’ methodology to gain
consensus by in silico and face to face meetings. The num-
ber of participants (> 12), and four rounds of written revi-
sions fulfilled the basic criteria required for a guideline
decision group (National Institute for Health and Clinical
Excellence, April 2007) and allowed a sufficiently reliable
process at an acceptable cost in terms of travel, expenses
etc. The heterogeneity of the group (specialty, nationality,
expertise) was deemed desirable to be representative of a
range of stakeholders. Agreement was defined without
‘weighting’ of any participant’s views, although some par-
ticipants contributed more than others to the process.
Using the synthesis of the evidence base the group
drafted statements of evidence based on best evidence
available (which varied significantly by procedure). The
clinical guidance group discussed, revised and graded
summary statements of evidence level using the Oxford
2009 CEBM system (http://www.cebm.net/oxford-ce
ntre-evidence-based-medicine-levels-evidence-march-2009)
(Table 2) based on the review of evidence. For clarity,
roman numerals (I–IV) were used to denote summary
levels of evidence for graded evidence in contrast to
Arabic numerals for individual studies, e.g. 1a, 2b etc.
Summary levels could apply either positively or nega-
tively to each procedure. Care was taken to avoid any
contamination of expert opinion into statements, these
thus solely reflecting summated evidence from system-
atic review. Some language used in summary evidence
statements was deliberately chosen to reflect use of
pooled data. Thus the term ‘typical’ or ‘typically’ specif-
ically denotes that data for the event in question have
been derived from random effects analysis.
Development of graded practice recommendations
(GPRs)
This had two main stages: (i) development of ‘prototype’
GPRs by the Clinical Guidance Group, and (ii) develop-
ment of a final GPR list by a European Consensus group.
This approach, including the methodology used
(RAND/UCLA – see below) is established and has been
used previously in the coloproctology field [26].
Development of prototype GPRs: After a common
understanding of the evidence was established, group
discussion balanced clinical experience and evidence sum-
maries to arrive at shared judgements about recommen-
dations for care, thus deriving relevant recommendations
for decision making in clinical practice. Group processes
risk personal bias based on ‘eminence’ or ‘eloquence’ if
led and supported ineffectively: adequate methodological
support in the use of evidence and dialectic was provided
to support the process to ensure a balance of views as well
as to promote generalizability and impact. This stage
embodied summary evidence statements (from each
review), data from some excluded level I studies (e.g.
RCTs that were excluded for short follow up or pub-
lished after the review date) (a further search was run by
CK on 03.10.16 for the date range 22.02.16 to 03.10.16
including original terms and ‘clinical trial’) and expert
opinion derived from the decision group and selected
prior published guidance documents (Oxford 5) (Fig. 2).
Final grading followed Oxford CEBM recommenda-
tions (A–D) [27] [Table 3]. As with levels of evidence
the grades of evidence could apply either positively or
negatively to the procedure.
Development of final GPRs: The European Consensus
group comprised a panel of European experts (colorectal
and pelvic floor surgeons) nominated by the European
Society of Coloproctology (ESCP). Twenty experts were
invited from 10 European countries of whom 18 partici-
pated from nine countries (Appendix II).
Consensus methodology was derived from the
RAND/UCLA Appropriateness Method (Prepared for
Directorate General XII, European Commission 2001)
[28]. Prototype Graded Practice Recommendations
(derived from the clinical guidance group) were pre-
sented (on a spreadsheet) for each procedure under three
subheadings: ‘patient selection’, ‘procedural considera-
tions’ and ‘patient counselling’. For each, a number of
GPRs were listed, each with associated levels of evidence
and grade of prototype recommendation. For each, con-
sensus panellists were asked ‘Does this recommendation
lead to an expected health benefit that exceeds the
expected negative consequences of its introduction?’
Examples of health benefits in this context could be
improved surgical outcome, improved patient experience,
improved functional capacity etc.; the negative conse-
quences could include increased morbidity, anxiety, pain,
time lost from work, denial of an investigation or treat-
ment. Panellists were asked to base their judgement on
clinical grounds only, i.e. exclusive of financial cost [29].
Responses to each listed recommendation used a lin-
ear analogue scale of 1–9 to assess views on the benefit-
to-harm ratio. Using this scale, a score of 1–3 indicated
that they expected the harms of introducing the recom-
mendation to greatly outweigh the expected benefits
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and a score of 7–9 that the expected benefits greatly
outweighed the expected harms. A middle rating of 4–6
could mean either that the harms and benefits were
considered about equal or that the panellist was unable
to make a judgement for the recommendation. Panel-
lists were asked to try and provide a response for all
listed recommendations.
Responses were analysed in accordance with the first
phase of RAND/UCLA guidance, with each recom-
mendation classified as ‘appropriate,’ ‘uncertain’ or
‘inappropriate’ according to the panellists’ median score
and the level of disagreement. Indications with median
scores in the 1–3 range were classified as inappropriate,
those in the 4–6 range as uncertain, and those in the 7–
9 range as appropriate. All indications rated ‘with dis-
agreement,’ whatever the median, were classified as
uncertain. ‘Disagreement’ here basically implied a lack
of consensus, either because of polarisation or spread
over the entire scale (defined for a sample of 18 pan-
elists as > 5 rating the indication outside the 3-point
region [1–9,28]). Further phases of consensus following
discussion to reduce variation were not conducted.
Summary research recommendations
One of the initial drivers for this process (NIHR Capa-
CiTY) was the need to define the main evidence needed
for future surgical trials of patients with CC. During
the development of this guidance, some trials have com-
menced patient recruitment such as CapaCiTY study 3
(RCT of laparoscopic ventral rectopexy). There is how-
ever still a great need to define research questions that
could inform future UK and international commission-
ing of research funding. Research recommendations
Table 2 (a) Oxford CEBM (2009) summary levels of evidence and (b) grades of recommendation.
(a) Summary level
of evidence Type of studies
Evidence
included specific
to review
Notes specific to review
exclusions
I High quality RCT
All or none study
Oxford 1b,
1c*
1a (SR RCTs) excluded since no
secondary research included in
systematic review
II Poor quality RCT
Individual high quality
cohort study
Ecological study
Oxford 2b
2c*
2a (SR cohort studies) excluded
since no secondary research
included in systematic review
III Individual high quality
case-control study
Oxford 3b* 3a (SR case-control studies)
excluded since no secondary
research included in systematic
review
IV Case series and poor
quality cohort and
case-control studies
Oxford 4 The majority of studies included
in systematic review
V Expert opinion, bench
research
Oxford 5 Excluded in systematic review
(b) Grades of recommendation Evidence required
A Consistent level 1 studies
B Consistent level 2 or 3 studies or extrapolations from level 1 studies
C Level 4 studies or extrapolations from level 2 or 3 studies
D Troublingly inconsistent or inconclusive studies of any level (I–IV)
N Recommendation based on clinical understanding in the absence of evidence†
*No studies of these designs found by search for any procedure.
†But where a recommendation was considered necessary to highlight the absence of evidence for an important practice point.
Figure 2 Schematic showing process of transition from sum-
mary evidence statements to graded practice recommendations.
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have been attributed a priority (high, medium or low)
based on the expert opinion of the current working
group and may help inform discussion about future
funding priorities.
Presentation of results
In view of the large scale of the systematic review and
prototype guidance process, results have been presented
as a series of separate manuscripts:
1 Overview of search results and study characteristics
(this manuscript);
2 Systematic review results and summary evidence
statements for colonic resection;
3 Systematic review results and summary evidence state-
ments for procedures characterized by rectal suspension;
4 Systematic review results and summary evidence state-
ments for procedures characterized by rectal wall excision;
5 Systematic review results and summary evidence
statements for procedures characterized by rectovagi-
nal septum reinforcement;
6 Systematic review results and summary evidence
statements for sacral nerve stimulation;
7 Coalescence of systematic review data, summary of graded
practice recommendations and research recommendations.
The main conclusions of this process were presented
at the Pelvic Floor Society Meeting in Cardiff, January
2017.
Overview of search results
Study selection
Figure 3 (PRISMA flow diagram) shows the results of
population and intervention term searches with reasons
for exclusion of studies at the full text review stage.
Table 3 Reviewed studies by main procedure type and evi-
dence level.
Procedure
Number of reviewed studies
by evidence level
1b 2b 3b 4 Total
Colonic resection 0 1 0 39 40
Rectal suspension procedures 0 2 0 16 18
Rectal excisional procedures 3 26 0 18 47
RV Reinforcement procedures 1 10 0 33 44
Sacral nerve stimulation 0 0 0 7 7
ALL 4 39 0 113 156
Figure 3 PRISMA diagram showing all review results.
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Study characteristics
Table 3 gives information on the overall study charac-
teristics and by procedure. Detailed data on individual
reviewed studies are provided by procedure type in the
accompanying papers. It can readily be noted that the
overall quality of evidence was poor with 113/156
(72.4%) providing only level IV evidence. The best evi-
dence to date exists for rectal excisional procedures
where the majority of studies where level I or II. This is
discussed further in the final graded practice recommen-
dations and research recommendations paper.
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Appendix I: Search strategy
Population terms
“constipation”[All Fields] OR “obstructed defecation”[All
Fields] OR “colonic inertia”[All Fields] OR
“intussusception”[All Fields] OR “rectal prolapse”[All Fields]
OR “outlet obstruction”[All fields] OR “SRUS”[All Fields]
OR “solitary rectal”[All Fields] OR “defecation disorder”[All
Fields]) OR “impaired defecation”[All Fields] OR “rectal
emptying”[All Fields] OR “bowel dysfunction”[All Fields]
OR “bowel function”[All Fields] OR “defecography”[All
Fields] OR “defaecography”[All Fields] OR
“defecographic”[All Fields] OR “evacuation difficulty”[All
Fields] OR “evacuation disorder”[All Fields] OR
(“Constipation”[Mesh Terms]) NOT (“child”[MeSH
Terms]).
Intervention terms
“Delorme procedure”[All Fields] OR “delormes
procedure”[All Fields] OR “delorme’s procedure”[All Fields]
OR “sacral nerve stimulation”[All Fields] OR “sacral
neuromodulation”[All Fields] OR “neurostimulation”[All
Fields] OR “sacral nerve modulation”[All Fields] OR
“STARR”[All Fields] OR “stapled transanal resection”[All
Fields] OR “stapled transanal rectal resection” [All Fields]
OR “trans-STARR”[All Fields] OR “Stapled trans-anal rectal
resection”[All Fields] OR “rectopexy”[All Fields] OR
“sacrocolpopexy”[All Fields] OR “sacropexy”[All Fields] OR
“promontofixation”[All Fields] OR “colectomy”[All Fields]
OR “proctocolectomy”[All Fields] OR “ileorectal”[All Fields]
OR “cecorectal” [All Fields] OR “ileoproctostomy”[All
Fields] OR “cecoproctostomy”[All Fields] OR
“ileosigmoid”[All Fields] OR “rectocele repair”[All Fields]
OR “posterior repair”[All Fields] OR “colporrhaphy”[All
Fields] OR “rectovaginal septum reinforcement”[All Fields]
OR “anterior rectal wall repair”[All Fields] OR “surgical
repair of rectocele”[All Fields] OR (“transperineal mesh
repair”[All Fields] OR “transperineal repair”[All Fields] OR
“transvaginal repair”[All Fields] OR “transanal repair”[All
Fields] OR “endorectal repair”[All Fields] OR “transrectal
repair”[All Fields] OR “transanal longitudinal plication”[All
Fields] OR (“Constipation/surgery”[Mesh Terms])
Report terms
(hasabstract[text]) AND (“0001/01/01”[PDat]: “2016/02/
22”[PDat])
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Appendix II: European reference group*
Name Institution
Donato Altomare Bari, Italy
Lars Boenicke Wuerzburg, Germany
Steen Buntzen Tromsø, Norway
Ken Campbell Dundee, UK
Peter Christensen Aarhus, Denmark
Andre D’Hoore Leuven, Belgium
Eloy Espin Barcelona, Spain
David Jayne Leeds, UK
Oliver Jones Oxford, UK
Jens-Christian Knapp Stavanger, Norway
Soren Laurberg Aarhus, Denmark
Paul Lehur Nantes, France
Klaus Matzel Erlangen, Germany
Ronan O’Connell Dublin, Ireland
Michel Prud’homme N^ımes, France
Carlo Ratto Rome, Italy
Mario Trompetto Turin, Italy
Caroline Vaizey London, UK
*Derived from European Society of Coloproctology.
ª 2017 The Authors. Colorectal Disease published by John Wiley & Sons Ltd
on behalf of Association of Coloproctology of Great Britain and Ireland. 19 (Suppl. 3), 5–1616
Surgery for constipation C. H. Knowles et al.
